Core Viewpoint - The well-known retail pharmacy chain, Lao Bai Xing, is experiencing increasing losses despite expanding its store network, raising concerns about its profitability and future strategies [2][3]. Financial Performance - In the first half of 2025, Lao Bai Xing reported revenue of 10.774 billion yuan, a year-on-year decrease of 1.51%, and a net profit attributable to shareholders of 398 million yuan, down 20.86% year-on-year [2]. - The company's gross margin for the same period was 33.08%, a decline of 1.24% compared to the previous year [3]. - The retail revenue from pharmaceuticals decreased by 2.30% year-on-year, with a gross margin drop of 1.07% [3]. Store Expansion and Market Competition - Lao Bai Xing added 108 new stores in the first half of 2025, with a net increase of 305 franchise stores and a decrease of 197 direct-operated stores [3]. - The competitive landscape among pharmacies is intensifying, leading to frequent promotions and price wars that compress profit margins [3]. - The total number of retail pharmacies in China has been declining, with a net reduction of approximately 3,000 stores in the first quarter of 2025, bringing the total below 700,000 [3]. Debt and Goodwill Concerns - Lao Bai Xing's short-term non-current liabilities reached 1.093 billion yuan, and long-term borrowings amounted to 1.321 billion yuan in the first half of 2025 [6]. - The company's goodwill has surged to 5.763 billion yuan, while its net assets stood at 6.733 billion yuan, raising concerns about potential goodwill impairment risks if future acquisitions underperform [6]. Shareholder Actions - Following the release of disappointing financial results, Lao Bai Xing's controlling shareholder, the Pharmaceutical Group, announced a plan to reduce its stake by up to 22.8029 million shares, representing 3% of the total share capital, potentially raising around 451 million yuan [8]. - The Pharmaceutical Group has engaged in multiple rounds of share pledging and unpledging, with 62.04% of its shares pledged as of June 30, 2025, indicating a strategy to manage short-term liquidity pressures [9].
知名连锁药店,越开店越亏?